Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI studyDaniëlle M. Gerlag, Paul P. Tak, Karen I. Maijer et al.|Annals of the Rheumatic Diseases|2018Cited by 289
Local treatment with the selective IκB kinase β inhibitor NEMO-binding domain peptide ameliorates synovial inflammationSander W. Tas, Paul P. Tak|Arthritis Research & Therapy|2006Cited by 74
Tertiary Lymphoid Structures in Rheumatoid ArthritisAe R Noort, Sander W. Tas|American Journal Of Pathology|2015Cited by 43
Nuclear Factor-κB–inducing Kinase Is Expressed in Synovial Endothelial Cells in Patients with Early Arthritis and Correlates with Markers of Inflammation: A Prospective Cohort StudyKaren I. Maijer, Sander W. Tas|The Journal of Rheumatology|2015Cited by 26
Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritisMerlijn H. Kaaij, Sander W. Tas|Scientific Reports|2020Cited by 15